Toledo, Ohio, October 21, 2017. Landing Med held the “Artificial Intelligence in Cervical Cancer Screening Innovation Forum” in Toledo this past weekend. The forum’s focus was on the world’s leading innovative technology for cervical cancer screening developed by Landing Med, as well as its clinical applications. As of today the cloud-based platform has been used to screen millions of cases across China.

Participants were mainly Chinese and American pathology and gynecology experts. During the event Landing Med demonstrated its artificial intelligence system with cloud computing which was well received by all attendees.

Landing is the first company in the world to use cloud computing in cervical cancer screening.